European Patent EP4370184A1 Deoxyhemoglobin MRI Contrast Agent, Thornhill Scientific, Apr 15
Summary
The European Patent Office granted patent EP4370184A1 to Thornhill Scientific Inc. on April 15, 2026, covering a method of inducing deoxyhemoglobin as a contrast agent in a subject for magnetic resonance imaging. The patent names seven inventors and classifies under A61M (medical devices). The designated states cover all 27 EU member states plus several EEA and associated countries including the UK, Switzerland, Norway, Turkey, and others.
About this source
GovPing monitors EPO Patent Bulletin - Medical Devices (A61M) for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 44 changes logged to date.
What changed
The EPO published European patent application EP4370184A1 for Thornhill Scientific Inc. on April 15, 2026. The invention relates to using induced deoxyhemoglobin as a contrast agent for MRI imaging, with applications in medical diagnostics. Seven inventors are named including Joseph Arnold Fisher, James Duffin, and David J. Mikulis.
Medical device manufacturers and biotechnology companies developing novel MRI contrast agents should review freedom-to-operate positions, as this granted European patent establishes exclusive rights across all designated contracting states including Germany, France, the UK, and the Netherlands. IP licensing discussions may be appropriate for parties seeking to develop competing deoxyhemoglobin-based imaging technologies in EU markets.
Archived snapshot
Apr 24, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
INDUCING DEOXYHEMOGLOBIN AS A CONTRAST AGENT IN A SUBJECT FOR MRI
Publication EP4370184A1 Kind: A1 Apr 15, 2026
Applicants
Thornhill Scientific Inc.
Inventors
FISHER, Joseph Arnold, DUFFIN, James, SOBCZYK, Olivia, SAYIN, Ece Su, POUBLANC, Julien, SCHULMAN, Jacob B., MIKULIS, David J
IPC Classifications
A61M 16/10 20060101AFI20250325BHEP A61M 16/12 20060101ALI20250325BHEP A61M 16/00 20060101ALI20250325BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Parties
Related changes
Get daily alerts for EPO Patent Bulletin - Medical Devices (A61M)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from EPO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when EPO Patent Bulletin - Medical Devices (A61M) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.